Literature DB >> 14766881

Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea.

Anne Jolivet-Gougeon1, Zohreh Tamanai-Shacoori, Laurent Desbordes, Nathalie Burggraeve, Michel Cormier, Martine Bonnaure-Mallet.   

Abstract

A beta-lactamase gene (cfxA3, 966 bp) was isolated from a beta-lactam-resistant Capnocytophaga ochracea clinical isolate and amplified using primers from the cfxA gene of Bacteroides vulgatus. The MICs of third-generation cephalosporins were much higher than those of the transconjugant Escherichia coli strain. The deduced protein sequence, by comparison with CfxA2 of Prevotella intermedia, had a Y239D substitution and possessed the characteristics of a class A, group 2e beta-lactamase.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14766881      PMCID： PMC344468          DOI： 10.1128/JCM.42.2.888-890.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  31 in total

1.  Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.

Authors:  A Rosenau; B Cattier; N Gousset; P Harriau; A Philippon; R Quentin
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Cloning and biochemical characterization of a class A beta-lactamase from Prevotella intermedia.

Authors:  I Madinier; T Fosse; J Giudicelli; R Labia
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  A beta-lactamase belonging to group 2e from oral clinical isolates of Prevotella intermedia.

Authors:  G Valle; L M Quirós; M T Andrés; J F Fierro
Journal:  FEMS Microbiol Lett       Date:  1998-01-15       Impact factor: 2.742

4.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study.

Authors:  R Martino; E Rámila; J A Capdevila; A Planes; M Rovira; G Plumé; L Gómez; J Sierra
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

6.  Rapid and efficient cosmid cloning.

Authors:  D Ish-Horowicz; J F Burke
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

7.  API ZYM system for identification of Bacteroides spp., Capnocytophaga spp., and spirochetes of oral origin.

Authors:  B E Laughon; S A Syed; W J Loesche
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

8.  Septicemia caused by Capnocytophaga in a granulocytopenic patient with glossitis.

Authors:  C Gandola; T Butler; S Badger; E Cheng; S Beard
Journal:  Arch Intern Med       Date:  1980-06

9.  Selective recovery of oral Capnocytophaga spp. with sheep blood agar containing bacitracin and polymyxin B.

Authors:  P A Mashimo; Y Yamamoto; M Nakamura; J Slots
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

10.  Enzymatic characterization of some oral and nonoral gram-negative bacteria with the API ZYM system.

Authors:  J Slots
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948
View more
  6 in total

1.  Analysis of the zinc finger domain of TnpA, a DNA targeting protein encoded by mobilizable transposon Tn4555.

Authors:  Melissa K Bacic; Jinesh C Jain; Anita C Parker; C Jeffrey Smith
Journal:  Plasmid       Date:  2007-01-03       Impact factor: 3.466

2.  Chromosome- and plasmid-encoded beta-lactamases in Capnocytophaga spp.

Authors:  Trude Handal; Chantal Giraud-Morin; Dominique A Caugant; Isabelle Madinier; Ingar Olsen; Thierry Fosse
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

3.  Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone.

Authors:  John F Kokai-Kun; Chenxiong Le; Kenneth Trout; Julia L Cope; Nadim J Ajami; Andrew J Degar; Sheila Connelly
Journal:  Infect Drug Resist       Date:  2020-07-22       Impact factor: 4.003

4.  The Brief Case: Capnocytophaga sputigena Bacteremia in a 94-Year-Old Male with Type 2 Diabetes Mellitus, Pancytopenia, and Bronchopneumonia.

Authors:  Benjamin M Liu; Christopher P Carlisle; Mark A Fisher; Salika M Shakir
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

5.  Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period.

Authors:  Anne Jolivet-Gougeon; Zohreh Tamanai-Shacoori; Laurent Desbordes; Virginie Gandemer; Jean-Louis Sixou; Nolwenn Morvan-Graveline; Michel Cormier; Martine Bonnaure-Mallet
Journal:  BMC Infect Dis       Date:  2005-05-09       Impact factor: 3.090

6.  Genomic diversity and antimicrobial resistance of Prevotella species isolated from chronic lung disease airways.

Authors:  Kasey A Webb; Olusola Olagoke; Timothy Baird; Jane Neill; Amy Pham; Timothy J Wells; Kay A Ramsay; Scott C Bell; Derek S Sarovich; Erin P Price
Journal:  Microb Genom       Date:  2022-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.